Who owns the THENDOR THERAPEUTICS trademark?

The THENDOR THERAPEUTICS trademark is owned by Thendor Therapeutics, Inc..

What is the serial number for THENDOR THERAPEUTICS?

The USPTO serial number for THENDOR THERAPEUTICS is 99542789.

What is the registration number for THENDOR THERAPEUTICS?

THENDOR THERAPEUTICS is registered under USPTO registration number 0.

THE

USPTO Trademark Record

PENDING

THENDOR THERAPEUTICS

Q: What class is the THENDOR THERAPEUTICS trademark registered in?

The THENDOR THERAPEUTICS trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

SN 99542789·Reg 0·Filed Dec 11, 2025

Owner Thendor Therapeutics, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

THENDOR THERAPEUTICS (Serial No. 99542789), Registration No. 0, is a pending US trademark filed on Dec 11, 2025 by Thendor Therapeutics, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

Statement of Use due: February 04, 202797 days remaining

Mark Intelligence

THENDOR THERAPEUTICS (Reg. #0) is a pending US trademark that was filed in 2025 and is currently under USPTO examination. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Dec 11, 2025

SERIAL

99542789

REG#

Owner

Applicant

Thendor Therapeutics, Inc.

Entity

Corporation

State

Address

5270 California Ave, Suite 300, Irvine, CA, 92617

Country

Attorney

NameJohn Paul Oleksiuk

Law firm

John Paul Oleksiuk Cooley LLP

Docket

351964-20000

Address

1299 Pennsylvania Avenue, NW, Suite 700, Washington, DC 20004, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusPENDING

Filing DateDec 11, 2025

Serial Number99542789

Registration No.0

Status DateAug 04, 2026

Published for OppositionJun 09, 2026

Mark TypeStandard characters

Attorney Docket351964-20000

Status DescriptionLive and pending, notice of allowance issued

Filing Signals

FILED

2025

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

Class 042Scientific, technology & SaaS services

US codes: 100, 101

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

15 events

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Aug 04, 2026

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Jun 09, 2026

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jun 09, 2026

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jun 03, 2026

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

May 14, 2026

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

May 12, 2026

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

May 12, 2026

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

May 12, 2026

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

Apr 01, 2026

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Apr 01, 2026

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Apr 01, 2026

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Mar 30, 2026

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Feb 12, 2026

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Dec 11, 2025

NEW APPLICATION ENTERED

APPLICATION FILING RECEIPT MAILED

Dec 11, 2025

APPLICATION FILING RECEIPT MAILED

THENDOR THERAPEUTICS

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Thendor Therapeutics, Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by John Paul Oleksiuk

Industries

USPTO Deadlines

Compare

Resources

Company